# OnCo record mslt-ii (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/mslt-ii/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "mslt-ii", "NCT00297895" ;
  schema:name "MSLT-II"@en ;
  schema:description "Showed that removing all the remaining lymph nodes after a positive sentinel node does not help patients live longer, ending a routine operation."@en ;
  schema:url <https://onco.cc/trials/mslt-ii/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00297895>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1613210> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2004-09-30" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/stage-iii-melanoma/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/ultrasound/> ;
  onco:people <https://onco.cc/people/mark-faries/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-mslt-ii-faries-nejm-2017/> .